{"id":"W2032132548","doi":"10.1046/j.1468-3083.17.s2.4.x","title":"Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical trial; Body surface area; Dermatology; Internal medicine; Randomized controlled trial; Surgery; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014636,0.0001797197,0.0009080446,0.0002812991,0.00004455754,0.000001009155,0.0003329621,0.0002643254,0.00001733169],"category_scores_gemma":[0.0004451908,0.0001217968,0.0001206264,0.0002113099,0.0004977239,0.00005153637,0.00007224255,0.0003997692,0.000002450735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001975558,"about_ca_system_score_gemma":0.0001504434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000051694,"about_ca_topic_score_gemma":0.00001862835,"domain_scores_codex":[0.9922259,0.005596509,0.001686602,0.000204959,0.00007534714,0.0002107206],"domain_scores_gemma":[0.9972711,0.0006151657,0.001763008,0.0001982939,0.0001128533,0.00003954151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09772679,0.008307897,0.8522527,0.0000988251,0.001725351,0.00009075103,0.004509963,0.0001024087,0.02215975,0.0001801461,0.0004742006,0.01237118],"study_design_scores_gemma":[0.03663937,0.007557138,0.8940488,0.000148974,0.0004383738,0.0007044488,0.0004359264,6.332801e-7,0.05862877,0.00003940142,0.001221594,0.0001365607],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980082,0.0007957849,0.00001380741,0.0004491838,0.0002602019,0.0003299942,0.0000414177,0.000002400053,0.00009904372],"genre_scores_gemma":[0.9996447,0.0001478551,0.0001052169,0.00003201686,0.0000156387,0.00000132634,0.000003487091,0.00001262768,0.0000371574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06108742,"threshold_uncertainty_score":0.4966731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02010016712135707,"score_gpt":0.2928549598225856,"score_spread":0.2727547927012285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}